Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer
- 5 November 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 324 (1), 154-165
- https://doi.org/10.1016/j.bbrc.2004.09.029
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Role of tumor-associated gangliosides in cancer progressionBiochimie, 2003
- Ganglioside GD1a Enhances VEGF-Induced Endothelial Cell Proliferation and MigrationBiochemical and Biophysical Research Communications, 2001
- Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.Glycoconjugate Journal, 2000
- Angiogenic and Angiostatic Microenvironment in Tumors:Role of GangliosidesActa Oncologica, 1997
- Vascular and perivascular GD3 expression in human gliomaCancer Letters, 1996
- Serum gangliosides as endogenous immunomodulatorsImmunology Today, 1995
- Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitroMolecular and Chemical Neuropathology, 1995
- Prostaglandins and Gangliosides of Tumor Microenvironment: Their Role in AngiogenesisActa Oncologica, 1995
- Gangliosides Elicit a T-Cell Independent Antibody ResponseJournal of Autoimmunity, 1993
- Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.Proceedings of the National Academy of Sciences, 1986